Cargando…

Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

Optimizing the metabolism of the myocardium is a new strategy for patients with ischemic heart disease. Many studies have reported beneficial effects of trimetazidine (TMZ) on the clinical prognosis of patients with ischemic heart disease, but whether these beneficial effects are extended to patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ying, Ma, Xiao-juan, Shi, Da-zhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569304/ https://www.ncbi.nlm.nih.gov/pubmed/26367001 http://dx.doi.org/10.1371/journal.pone.0137775

Ejemplares similares

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Tang, Xiuying, et al.
Publicado: (2022)

Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
por: Shao, Shuai, et al.
Publicado: (2019)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury
por: Kazmi, Danish H., et al.
Publicado: (2018)

Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Demirelli, Selami, et al.
Publicado: (2013)

Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis
por: ZHOU, HONG, et al.
Publicado: (2013)

Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery Disease
por: Yaman, Mehmet, et al.
Publicado: (2016)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

Effect of trimetazidine on heart rate variability in elderly patients with acute coronary syndrome
por: Zhang, Jing, et al.
Publicado: (2016)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Ahmad Hamdi, Abdul Hafeez, et al.
Publicado: (2017)

Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
por: Zhu, Xiang, et al.
Publicado: (2022)

Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
por: Shi, Wenhai, et al.
Publicado: (2019)

Effect of prediabetes on the long-term all-cause mortality of patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta analysis
por: Shi, Rui, et al.
Publicado: (2020)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network
por: Chen, Chunhua
Publicado: (2021)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis
por: Gelbenegger, Georg, et al.
Publicado: (2021)

Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions
por: Li, Ruogu, et al.
Publicado: (2014)

Meta-analysis of Unguided Deescalation of Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Mohamed, Mohamed M. G., et al.
Publicado: (2022)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
por: Tsoulou, Vasiliki, et al.
Publicado: (2023)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
por: QU, Li, et al.
Publicado: (2018)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis
por: Li, Yan, et al.
Publicado: (2020)

High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Chen, Yu, et al.
Publicado: (2013)

Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis
por: Gong, Xiaoxuan, et al.
Publicado: (2017)

Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials
por: Wang, Xiaobing, et al.
Publicado: (2018)

Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China
por: Liu, Ying, et al.
Publicado: (2022)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Trimetazidine in angina and poor muscle function: protocol for a randomized controlled study
por: Zhang, Yu-Jie, et al.
Publicado: (2019)

The Prognostic Value of a Derived Neutrophil-Lymphocyte Ratio in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Fan, Wenjun, et al.
Publicado: (2021)

Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Zhang, Juan, et al.
Publicado: (2017)

Magnetic navigation system for percutaneous coronary intervention: A meta-analysis
por: Qi, Zhiyong, et al.
Publicado: (2016)

Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Liu, Xiao-Qiang, et al.
Publicado: (2020)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n1ffb05utnmrthavgqri8t67q8